Abstract
To provide a 2-substituted-6-(pyrazolopyridin-3-yl)pyridazinone derivative useful as a medicine having a phosphodiesterase (PDE) inhibitory activity. ; SOLUTION: This 2-substituted-6-(pyrazolopyridin-3-yl)pyridazinone derivative is expressed by general formula (1).
| Translated title of the contribution | 2-SUBSTITUTED-6-(PYRAZOLOPYRIDIN-3-YL)PYRIDAZINONE DERIVATIVE, ADDUCT SALT OF THE SAME AND PDE INHIBITOR BY USING THEM AS ACTIVE INGREDIENT |
|---|---|
| Original language | Other |
| Patent number | JP2008239558(A) |
| IPC | A61K31/501; A61P1/04; A61P11/06; A61P15/10; A61P17/00; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P29/00; A61P37/08; A61P43/00; A61P9/04; A61P9/10; A61P9/12; C07D471/04 |
| Publication status | Published - 9 Oct 2008 |
Fingerprint
Dive into the research topics of '2-SUBSTITUTED-6-(PYRAZOLOPYRIDIN-3-YL)PYRIDAZINONE DERIVATIVE, ADDUCT SALT OF THE SAME AND PDE INHIBITOR BY USING THEM AS ACTIVE INGREDIENT'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver